Atrás
18
Rango del Día
$295.90
$305.39
Rango de 52 Semanas
$275.05
$414.15
Volumen
507,303
Promedio 50D / 200D
$344.13
/
$339.49
Cierre Anterior
$301.81
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 28.0 | 0.4 |
| P/B | 7.0 | 2.9 |
| ROE % | 29.3 | 3.7 |
| Net Margin % | 20.3 | 3.9 |
| Rev Growth 5Y % | 3.2 | 10.0 |
| D/E | 0.6 | 0.2 |
Precio Objetivo de Analistas
Hold
$401.00
+32.8%
Low: $350.00
High: $480.00
P/E Futuro
21.0
EPS Futuro
$14.38
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
6.4 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$21.59
$21.03 – $21.98
|
8.3 B | 1 |
| FY2029 |
$20.27
$19.75 – $20.63
|
8 B | 1 |
| FY2028 |
$17.87
$16.68 – $19.62
|
7.5 B | 3 |
Puntos Clave
Revenue grew 3.24% annually over 5 years — modest growth
ROE of 29.28% indicates high profitability
Net margin of 20.30% shows strong profitability
Generating 539.81M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.75%
Cash machine — converts 84.00% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
3.24%
Revenue (1Y)6.99%
Earnings (1Y)0.75%
FCF Growth (3Y)10.49%
Calidad
Return on Equity
29.28%
ROIC16.88%
Net Margin20.30%
Op. Margin28.22%
Seguridad
Debt / Equity
0.55
Current RatioN/A
Interest Coverage17.59
Valoración
P/E Ratio
27.96
P/B Ratio7.01
EV/EBITDA21.03
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.99% | Revenue Growth (3Y) | 3.47% |
| Earnings Growth (1Y) | 0.75% | Earnings Growth (3Y) | 0.03% |
| Revenue Growth (5Y) | 3.24% | Earnings Growth (5Y) | -1.86% |
| Profitability | |||
| Revenue (TTM) | 3.17B | Net Income (TTM) | 642.63M |
| ROE | 29.28% | ROA | 12.64% |
| Gross Margin | 57.77% | Operating Margin | 28.22% |
| Net Margin | 20.30% | Free Cash Flow (TTM) | 539.81M |
| ROIC | 16.88% | FCF Growth (3Y) | 10.49% |
| Safety | |||
| Debt / Equity | 0.55 | Current Ratio | N/A |
| Interest Coverage | 17.59 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 27.96 | P/B Ratio | 7.01 |
| P/S Ratio | 5.68 | PEG Ratio | 75.62 |
| EV/EBITDA | 21.03 | Dividend Yield | 0.00% |
| Market Cap | 17.97B | Enterprise Value | 18.79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.17B | 2.96B | 2.96B | 2.97B | 2.79B |
| Net Income | 642.63M | 637.83M | 642.23M | 707.76M | 692.84M |
| EPS (Diluted) | 10.76 | 10.71 | 10.84 | 11.73 | 11.17 |
| Gross Profit | 1.83B | 1.76B | 1.76B | 1.72B | 1.63B |
| Operating Income | 893.22M | 826.35M | 817.68M | 873.40M | 821.71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.08B | 4.55B | 4.63B | 3.28B | 3.09B |
| Total Liabilities | 2.52B | 2.73B | 3.48B | 2.78B | 2.73B |
| Shareholders' Equity | 2.56B | 1.83B | 1.15B | 504.49M | 367.55M |
| Total Debt | 1.41B | 1.70B | 2.44B | 1.66B | 1.60B |
| Cash & Equivalents | 587.83M | 324.42M | 395.08M | 480.53M | 501.23M |
| Current Assets | 1.99B | 1.67B | 1.75B | 1.76B | 1.63B |
| Current Liabilities | 0.0 | 789.76M | 789.58M | 785.74M | 680.51M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#999 of 1052
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026